US Stock MarketDetailed Quotes
BBLG Bone Biologics
- 1.2316
- -0.0284-2.25%
Trading Nov 29 12:28 ET
3.03MMarket Cap-351P/E (TTM)
1.2955High1.1000Low90.73KVolume1.2700Open1.2600Pre Close107.18KTurnover3.76%Turnover RatioLossP/E (Static)2.46MShares10.560052wk High0.80P/B2.97MFloat Cap0.800052wk Low--Dividend TTM2.41MShs Float1709.2560Historical High--Div YieldTTM15.52%Amplitude0.8000Historical Low1.1810Avg Price1Lot Size
Bone Biologics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | 0 | 0 | ||||||||
| Operating expense | -54.30%951.02K | -73.37%809.67K | -71.29%903.54K | 157.24%9.43M | -9.87%1.16M | 70.67%2.08M | 547.74%3.04M | 356.50%3.15M | 232.27%3.67M | 179.51%1.29M |
| Selling and administrative expenses | 3.01%521.27K | -38.33%459.22K | 18.14%657.91K | 20.84%2.52M | 34.21%712.93K | 12.49%506.04K | 64.85%744.62K | -14.73%556.89K | 104.29%2.09M | 24.71%531.21K |
| -General and administrative expense | 3.01%521.27K | -38.33%459.22K | 18.14%657.91K | 20.84%2.52M | 34.21%712.93K | 12.49%506.04K | 64.85%744.62K | -14.73%556.89K | 104.29%2.09M | 24.71%531.21K |
| Research and development costs | -72.71%429.75K | -84.73%350.44K | -90.52%245.63K | 337.40%6.91M | -40.85%447.08K | 104.68%1.57M | 12,941.20%2.3M | 7,017.16%2.59M | 1,824.94%1.58M | 2,089.20%755.89K |
| Operating profit | 54.30%-951.02K | 73.37%-809.67K | 71.29%-903.54K | -157.24%-9.43M | 9.87%-1.16M | -70.67%-2.08M | -547.74%-3.04M | -356.50%-3.15M | -232.27%-3.67M | -179.51%-1.29M |
| Net non-operating interest income expense | 3,630.04%19.99K | 3,439.02%15.15K | -54.14%255 | 100.26%1.87K | 100.05%349 | 536 | 428 | 556 | 9.12%-731.71K | -4,859.09%-731.71K |
| Non-operating interest income | 3,630.04%19.99K | 3,439.02%15.15K | -54.14%255 | --1.87K | --349 | --536 | --428 | --556 | --0 | --0 |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --731.71K | ---- |
| Other net income (expense) | -106.21%-9.97K | -99.15%10.79K | 106.63%37.31K | -83.60%477.7K | -390.23K | 160.65K | 1.27M | -562.92K | 878.91%2.91M | |
| Gain on sale of security | -106.21%-9.97K | -99.15%10.79K | 106.63%37.31K | -69.35%892.69K | --24.76K | --160.65K | --1.27M | ---562.92K | --2.91M | ---- |
| Special income (charges) | ---- | ---- | ---- | ---414.99K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --414.99K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 50.98%-941K | 55.70%-783.73K | 76.66%-865.97K | -502.76%-8.95M | -273.47%-1.55M | -57.45%-1.92M | -276.99%-1.77M | -438.06%-3.71M | 7.83%-1.48M | 602.69%893.46K |
| Income tax | ||||||||||
| Net income | 50.98%-941K | 55.70%-783.73K | 76.66%-865.97K | -502.76%-8.95M | -273.47%-1.55M | -57.45%-1.92M | -276.99%-1.77M | -438.06%-3.71M | 7.83%-1.48M | 602.69%893.46K |
| Net income continuous Operations | 50.98%-941K | 55.70%-783.73K | 76.66%-865.97K | -502.76%-8.95M | -273.47%-1.55M | -57.45%-1.92M | -276.99%-1.77M | -438.06%-3.71M | 7.83%-1.48M | 602.69%893.46K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 50.98%-941K | 55.70%-783.73K | 76.66%-865.97K | -502.76%-8.95M | -273.47%-1.55M | -57.45%-1.92M | -276.99%-1.77M | -438.06%-3.71M | 7.83%-1.48M | 602.69%893.46K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 3.21M | 0 | ||||||||
| Net income attributable to common stockholders | -116.36%-4.15M | 55.70%-783.73K | 76.66%-865.97K | -502.76%-8.95M | -273.47%-1.55M | -57.45%-1.92M | -276.99%-1.77M | -438.06%-3.71M | 7.83%-1.48M | 602.69%893.46K |
| Basic earnings per share | 51.63%-2.37 | 87.14%-0.67 | 97.63%-1.31 | -9.18%-34.01 | -112.10%-2.9011 | 82.65%-4.9 | 52.11%-5.21 | -228.57%-55.2 | 62.92%-31.15 | 681.62%23.97 |
| Diluted earnings per share | 51.63%-2.37 | 87.14%-0.67 | 97.63%-1.31 | -9.18%-34.01 | -112.10%-2.9011 | 82.65%-4.9 | 52.11%-5.21 | -228.57%-55.2 | 62.92%-31.15 | 681.62%23.97 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data